STROKE

  • Up to 70% of TIA/stroke survivors have Sleep Apnea.

(Study Details | NCT04322162 | Addressing Sleep Apnea Post-Stroke/TIA | ClinicalTrials.gov)

 

DEMENTIA

  • Untreated OSA has been linked to a 29% increased risk of vascular dementia and a 12% higher risk of all-cause dementia.

(Study Details | NCT01800214 | The Sunnybrook Dementia Study | ClinicalTrials.gov)

  • Multiple factors stemming from OSA, including disrupted sleep architecture, recurrent hypoxia, and associated vascular comorbidities, are believed to contribute to the development of Alzheimer's disease and broader cognitive decline.

(PubMed, Obstructive sleep apnea and Alzheimer's disease: a systematic review)

  • OSA contributes to neurodegenerative and neurovascular damage, which are identified as key mechanisms in the progression of dementia.

(Oxford Academic, Sleep Medicine, Obstructive Sleep Apnea &Dementia: A Systematic Review)

 

STRESS ON THE HEART

HYPERTENSION

  • The prevalence of hypertension in patients with untreated OSA is approximately 71%.

(Medscape, Obstructive Sleep Apnea and Hypertension)

  • OSA is recognized as the second leading cause of hypertension, affecting approximately half of all OSA patients who develop the condition.

(National Institutes of Health (NIH), Sleep Apnea and High Blood Pressure)

 

CORONARY ARTERY DISEASE

 

CARDIAC ARRHYTHMIAS

  • The prevalence of cardiac arrhythmias in individuals with OSA exceeds 60%, with OSA patients being approximately 4 times as likely to experience atrial fibrillation.

(PubMed, Sleep apnea and cardiac arrhythmias)

 

HEART DISEASE

  • Up to 70% of individuals with cardiovascular disease are also found to have OSA.

(Medscape, Obstructive Sleep Apnea and Heart Disease)

 

CONGESTIVE HEART FAILURE

  • Approximately 35% of all patients diagnosed with Congestive Heart Failure (CHF) are likely to have untreated OSA. (PubMed, Sleep apnea in congestive heart failure)
  • Adults with untreated OSA are estimated to develop Congestive Heart Failure over time, with a 15% increased risk.

(PubMed, Obstructive sleep apnea and risk of incident heart failure: a meta-analysis)

  

POOR SLEEP

MOOD DISTURBANCE

  • The prevalence of mood disturbances, including anxiety and depression, in individuals with untreated OSA is reported at 35%.

(PubMed, The relationship between obstructive sleep apnea and mood disorders)

  • These disturbances can manifest as symptoms such as anxiety, depression, loss of motivation, shortened attention span, moodiness, bad temper, and poor judgment.

(NIH, Sleep Deprivation and Deficiency)

 

DAYTIME SLEEPINESS

 

SEXUAL DYSFUNCTION

  • A high prevalence of sexual dysfunction is observed in patients with OSA.

(Medscape, Obstructive Sleep Apnea and Sexual Dysfunction)

 

NOCTURIA

GASTROESOPHAGEAL REFLUX DISEASE (GERD)

  • The prevalence of GERD in patients with untreated OSA is estimated to be 32%.

(Medscape, Obstructive Sleep Apnea and GERD)

 

DIABETES TYPE II

  • The prevalence of OSA in Type II diabetes patients can be as high as 58%.

(PubMed, The prevalence of sleep apnea in patients with type 2 diabetes mellitus: a systematic review and meta-analysis)

  • OSA is associated with poor insulin control and poorly regulated blood sugar levels.

(NIH, Sleep Apnea and Type 2 Diabetes)

 

OBESITY

  • Obesity is present in approximately 61% of untreated OSA cases.

(PubMed, Prevalence of obesity in obstructive sleep apnea)

  • Diminished sleep quality and duration due to OSA can increase appetite for high-calorie foods, contributing to weight gain. (NIH, How Does Sleep Affect Weight?)
  • Approximately 80% of OSA patients weigh 130% or more of their ideal body weight.

(Medscape, Obstructive Sleep Apnea and Obesity)